MARKET

UPB

UPB

UpStream Bio Inc.
NASDAQ
6.12
-0.75
-10.92%
After Hours: 6.12 0 0.00% 16:36 03/31 EDT
OPEN
6.61
PREV CLOSE
6.87
HIGH
6.61
LOW
6.12
VOLUME
279.42K
TURNOVER
--
52 WEEK HIGH
29.46
52 WEEK LOW
6.12
MARKET CAP
328.01M
P/E (TTM)
-4.1129
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at UPB last week (0324-0328)?
Weekly Report · 15h ago
Weekly Report: what happened at UPB last week (0317-0321)?
Weekly Report · 03/24 12:34
Weekly Report: what happened at UPB last week (0310-0314)?
Weekly Report · 03/17 12:51
Upstream Bio Q3 Sales $613.00K Miss $686.67K Estimate
Benzinga · 03/12 11:21
Press Release: Upstream Bio Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Business Highlights
Dow Jones · 03/12 11:12
*Upstream Bio 4Q Loss $21.2M >UPB
Dow Jones · 03/12 11:09
*Upstream Bio: Runway Through 2027 >UPB
Dow Jones · 03/12 11:09
Press Release: Upstream Bio Reports Fourth -2-
Dow Jones · 03/12 11:00
More
About UPB
More
Upstream Bio, Inc. is a clinical-stage biotechnology company developing treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. The Company is developing verekitug, the only known antagonist in development that targets the receptor for thymic stromal lymphopoietin (TSLP), a cytokine which is a clinically validated driver of inflammatory response positioned upstream of multiple signaling cascades that affect a variety of immune mediated diseases. TSLP is a member of a class of epithelial cytokines, also including IL-25 and IL-33, referred to as alarmins. TSLP is primarily produced by epithelial cells, especially in the lung, gastrointestinal tract and skin. The Company has advanced this highly potent monoclonal antibody into separate Phase II trials for the treatment of severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) and plans to initiate development of chronic obstructive pulmonary disease (COPD).
Recently
Symbol
Price
%Change

Webull offers UpStream Bio Inc. stock information, including NASDAQ: UPB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, UPB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading UPB stock methods without spending real money on the virtual paper trading platform.